论文部分内容阅读
目的 探讨阿拓莫兰治疗慢性乙型肝炎的临床疗效及不良反应。方法 选择 15 4例在我院住院的慢性乙型肝炎患者 ,随机分成治疗组和对照组。其中对照组 76例 ,给予肝泰乐、门冬氨酸钾镁、齐敦果酸片、维生素等综合护肝治疗 ;治疗组 78例 ,在对照组治疗基础上加用阿拓莫兰 12 0 0mg静推或加入 10 %葡萄糖注射液 2 5 0ml中静滴 ,每日一次 ,4周为一疗程 ,治疗 2个疗程。结果 疗程结束时 ,按疗效判定标准 ,治疗组临床显效率 74 3 %,总有效率 92 3 %;而对照组临床显效率 65 8%,总有效率 81 6%,有显著的统计学意义 (P <0 0 5 ) ,未见严重的药物不良反应。结论 阿拓莫兰是一种有效的慢性乙型肝炎辅助治疗药物 ,能缩短病程 ,防止肝炎恶化 ,且无毒副作用
Objective To investigate the clinical efficacy and side effects of metoprolol in the treatment of chronic hepatitis B. Methods Fifty-four patients with chronic hepatitis B who were hospitalized in our hospital were randomly divided into treatment group and control group. 76 cases in the control group were treated with Gualutamide, Potassium Magnesium aspartate, Qiudan Tablets, vitamins and so on. In the treatment group, 78 cases were treated with Altraolan 120 0mg static push or join 10% glucose injection 250ml intravenous infusion once daily for 4 weeks for a course of treatment for 2 courses. Results At the end of the course of treatment, the clinical effective rate was 74.3% and the total effective rate was 93.3% in the treatment group, while the clinical effective rate was 65.8% and the total effective rate was 81.6% in the control group, with significant statistical significance P <0 0 5), no serious adverse drug reactions. Conclusion Addon Moran is an effective adjuvant treatment of chronic hepatitis B, can shorten the course of the disease, prevent the deterioration of hepatitis, and no toxic side effects